Latest Breaking News On - Ts alval fr0013254851 - Page 1 : comparemela.com

Valbiotis , a commercially oriented Research and Development company, committed to scientific innovation for preventing and combating metabolic and cardiovascular diseases, announces its Combined. | May 3, 2023

Espace encanEuropean unionResearch developmentInnovative companyEuropean regional development fundAnnual shareholdersCombined annual shareholders meetingSupervisory boardGeneral meetingShareholder meetingQuebec cityValbiotis stock exchangePress releaseTs alval fr0013254851